| Report ID | 277781 |
| Drug Identification Number | 02544083 |
| Brand name | DEXRAZOXANE FOR INJECTION |
| Common or Proper name | DEXRAZOXANE FOR INJECTION |
| Company Name | JUNO PHARMACEUTICALS CORP. |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXRAZOXANE |
| Strength(s) | 250MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1 x 250mg vial / fiole |
| ATC code | V03AF |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2026-02-06 |
| Estimated end date | |
| Actual end date | 2026-03-02 |
| Shortage status | Resolved |
| Updated date | 2026-03-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2233 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 2X7 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2026-03-04 | French | Compare |
| v5 | 2026-03-04 | English | Compare |
| v4 | 2026-02-27 | French | Compare |
| v3 | 2026-02-27 | English | Compare |
| v2 | 2026-02-10 | French | Compare |
| v1 | 2026-02-10 | English | Compare |
Showing 1 to 6 of 6